282 related articles for article (PubMed ID: 19775337)
1. Biologic markers in endometrial cancer treatment.
Engelsen IB; Akslen LA; Salvesen HB
APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers as prognostic factors in endometrial cancer.
Dobrzycka B; Terlikowski SJ
Folia Histochem Cytobiol; 2010 Sep; 48(3):319-22. PubMed ID: 21071332
[TBL] [Abstract][Full Text] [Related]
3. Management of early-stage endometrial cancer.
Lu KH
Semin Oncol; 2009 Apr; 36(2):137-44. PubMed ID: 19332248
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer: current concepts and management.
Ball HG; Elkadry EA
Surg Oncol Clin N Am; 1998 Apr; 7(2):271-84. PubMed ID: 9537976
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for advanced endometrial carcinoma.
Dizon DS
Gynecol Oncol; 2010 May; 117(2):373-81. PubMed ID: 20223510
[TBL] [Abstract][Full Text] [Related]
6. Endometrial adenocarcinoma.
Noumoff JS; Faruqi S
Microsc Res Tech; 1993 Jun; 25(3):246-54. PubMed ID: 8400424
[TBL] [Abstract][Full Text] [Related]
7. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
9. Recurrent endometrial cancer.
Del Carmen MG; Boruta DM; Schorge JO
Clin Obstet Gynecol; 2011 Jun; 54(2):266-77. PubMed ID: 21508696
[TBL] [Abstract][Full Text] [Related]
10. Endometrial hyperplasia and endometrial cancer.
Burke TW; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
Obstet Gynecol Clin North Am; 1996 Jun; 23(2):411-56. PubMed ID: 8784886
[TBL] [Abstract][Full Text] [Related]
11. Screening and the prevention of gynecologic cancer: endometrial cancer.
Sonoda Y; Barakat RR
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):363-77. PubMed ID: 16364689
[TBL] [Abstract][Full Text] [Related]
12. Update in the management of endometrial cancer.
Levine DA; Hoskins WJ
Cancer J; 2002; 8 Suppl 1():S31-40. PubMed ID: 12075700
[TBL] [Abstract][Full Text] [Related]
13. When is a pathology review indicated in endometrial cancer?
Kwon JS; Francis JA; Qiu F; Weir MM; Ettler HC
Obstet Gynecol; 2007 Dec; 110(6):1224-30. PubMed ID: 18055713
[TBL] [Abstract][Full Text] [Related]
14. Treatment modalities in endometrial cancer.
Amant F; Moerman P; Neven P; Timmerman D; Van Limbergen E; Vergote I
Curr Opin Oncol; 2007 Sep; 19(5):479-85. PubMed ID: 17762575
[TBL] [Abstract][Full Text] [Related]
15. L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas.
Fogel M; Huszar M; Altevogt P; Ben-Arie A
Expert Rev Mol Diagn; 2004 Jul; 4(4):455-62. PubMed ID: 15225093
[TBL] [Abstract][Full Text] [Related]
16. Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.
Llauradó M; Ruiz A; Majem B; Ertekin T; Colás E; Pedrola N; Devis L; Rigau M; Sequeiros T; Montes M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellví J; Garcia A; Ramón y Cajal S; Moreno G; Alameda F; Vázquez-Levin M; Palacios J; Prat J; Doll A; Matías-Guiu X; Abal M; Reventós J
Mol Cell Endocrinol; 2012 Jul; 358(2):244-55. PubMed ID: 22037169
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
Dellinger TH; Monk BJ
Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
[TBL] [Abstract][Full Text] [Related]
18. Complete pelvic lymphadenectomy in patients with clinical early, grade I and II endometrioid corpus cancer.
Fotiou S; Trimble EL; Papakonstantinou K; Kondi-Pafiti A; Panoskaltsis T; Deliconstantinos G; Creatsas G
Anticancer Res; 2009 Jul; 29(7):2781-5. PubMed ID: 19596961
[TBL] [Abstract][Full Text] [Related]
19. The management of serous papillary uterine cancer.
Schwartz PE
Curr Opin Oncol; 2006 Sep; 18(5):494-9. PubMed ID: 16894299
[TBL] [Abstract][Full Text] [Related]
20. Endometrial cancer.
Amant F; Moerman P; Neven P; Timmerman D; Van Limbergen E; Vergote I
Lancet; 2005 Aug 6-12; 366(9484):491-505. PubMed ID: 16084259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
